Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
World J Gastroenterol ; 21(1): 177-86, 2015 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-25574090

RESUMEN

AIM: To investigate the effect of a fat rich diet on non-steroidal anti-inflammatory drug (NSAID)-induced mucosal damage in the murine small intestine. METHODS: C57BL6 mice were fed 4 types of diets with or without indomethacin. One group was fed standard laboratory chow. The other groups were fed a fat diet consisting of 8% w/w fat, beef tallow (rich in SFA), fish oil, (rich in omega-3 PUFA), or safflower oil (rich in omega-6 PUFA). Indomethacin (3 mg/kg) was injected intraperitoneally from day 8 to day 10. On day 11, intestines and adhesions to submucosal microvessels were examined. RESULTS: In the indomethacin-treated groups, mucosal damage was exacerbated by diets containing beef tallow and fish oil, and was accompanied by leukocyte infiltration (P < 0.05). The mucosal damage induced by indomethacin was significantly lower in mice fed the safflower oil diet than in mice fed the beef tallow or fish oil diet (P < 0.05). Indomethacin increased monocyte and platelet migration to the intestinal mucosa, whereas safflower oil significantly decreased monocyte and platelet recruitment (P < 0.05). CONCLUSION: A diet rich in SFA and omega-3 PUFA exacerbated NSAID-induced small intestinal damage via increased leukocyte infiltration. Importantly, a diet rich in omega-6-PUFA did not aggravate inflammation as monocyte migration was blocked.


Asunto(s)
Antiinflamatorios no Esteroideos/toxicidad , Dieta , Ácidos Grasos Omega-6/administración & dosificación , Indometacina/toxicidad , Mucosa Intestinal/irrigación sanguínea , Mucosa Intestinal/efectos de los fármacos , Intestino Delgado/irrigación sanguínea , Intestino Delgado/efectos de los fármacos , Aceite de Cártamo/administración & dosificación , Animales , Plaquetas/efectos de los fármacos , Plaquetas/inmunología , Plaquetas/metabolismo , Adhesión Celular/efectos de los fármacos , Moléculas de Adhesión Celular/genética , Moléculas de Adhesión Celular/metabolismo , Quimiotaxis de Leucocito/efectos de los fármacos , Aceites de Pescado/administración & dosificación , Aceites de Pescado/toxicidad , Mucosa Intestinal/inmunología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Intestino Delgado/inmunología , Intestino Delgado/metabolismo , Intestino Delgado/patología , Leucocitos/efectos de los fármacos , Leucocitos/inmunología , Leucocitos/metabolismo , Masculino , Productos de la Carne/toxicidad , Ratones Endogámicos C57BL , Microvasos/efectos de los fármacos , Microvasos/inmunología , Microvasos/metabolismo , ARN Mensajero/metabolismo , Factores de Tiempo
2.
Am J Physiol Gastrointest Liver Physiol ; 304(8): G708-14, 2013 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-23370677

RESUMEN

Glucagon-like peptide-2 (GLP-2) is a potent intestinal growth factor derived from enteroendocrine L cells. Although food intake is known to increase GLP-2 secretion, its regulatory mechanisms are largely unknown as a result of its very short half-life in venules. The aims of this study were to compare the effects of luminal nutrients on the stimulation of GLP-2 secretion in vivo using lymph samples and to clarify the involvement of the sweet taste receptor in this process in vitro. Lymph samples were collected from the thoracic duct after bolus administration of dietary lipids or sweetening agents into the duodenum of rats. Human enteroendocrine NCI-H716 cells were also used to compare the effects of various nutrients on GLP-2 secretion. GLP-2 concentrations were measured by ELISA in vivo and in vitro. GLP-2 secretion was enhanced by polyunsaturated fatty acid- and monounsaturated fatty acid-rich dietary oils, dietary carbohydrates, and some kinds of sweeteners in rats; this effect was reproduced in NCI-H716 cells using α-linolenic acid (αLA), glucose, and sweeteners. GLP-2 secretion induced by sweetening agents was inhibited by lactisole, a sweetness-antagonizing inhibitor of T1R3. In contrast, lactisole was unable to inhibit GLP-2 secretion induced by αLA alone. Our results suggested that fatty acid- and sweetener-induced GLP-2 secretion may be mediated by two different pathways, with the sweet taste receptor involved in the regulation of the latter.


Asunto(s)
Grasas de la Dieta/farmacología , Células Enteroendocrinas/metabolismo , Péptido 2 Similar al Glucagón/metabolismo , Edulcorantes/farmacología , Gusto/fisiología , Animales , Derivados del Benceno/farmacología , Línea Celular Tumoral , Carbohidratos de la Dieta/farmacología , Células Enteroendocrinas/citología , Ácidos Grasos Monoinsaturados/farmacología , Ácidos Grasos Insaturados/farmacología , Glucosa/farmacología , Humanos , Sistema Linfático/metabolismo , Masculino , Ratas , Ratas Wistar , Conducto Torácico/metabolismo , Vénulas/metabolismo
3.
Microcirculation ; 17(5): 321-32, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20618690

RESUMEN

OBJECTIVE: Aberrant leukocyte migration has been implicated in the pathogenesis of inflammatory bowel disease (IBD). Lemon grass is a natural herb that contains citral, which suppresses lymphocyte expression of gut homing molecules by inhibiting retinoic acid formation. We therefore hypothesized that lemon grass intake could ameliorate excess migration of leukocytes to the inflamed intestine in chronic ileitis. METHODS: Migration of fluorescence-labeled T cells to microvessels in the ileal mucosa of SAMP1/Yit mice was monitored using intravital microscopy. In some mice, lemon grass solution was administered for two weeks. For evaluation of the effects on chronic ileitis, mice were treated with lemon grass for 26 weeks. RESULTS: Surface expression of beta7 and CCR9 on T lymphocytes was stronger in SAMP1/Yit mice than in AKR/J mice. Lemon grass treatment attenuated the surface expression of beta7-integrin and CCR9. The number of adherent lymphocytes to microvessels in chronic inflamed ileum was significantly few when lymphocytes were isolated from lemon grass treated mice. Long-term lemon grass treatment improved ileitis in SAMP1/Yit mice, which was assessed by body weight, histological changes and the infiltration of beta7-positive cells. CONCLUSION: Lemon grass ameliorated ileitis through decreasing lymphocyte migration by inhibiting beta7-expression, suggesting its therapeutic usefulness for IBD.


Asunto(s)
Cymbopogon , Ileítis/tratamiento farmacológico , Fitoterapia , Linfocitos T/efectos de los fármacos , Oxidorreductasas de Alcohol/genética , Oxidorreductasas de Alcohol/metabolismo , Animales , Movimiento Celular/efectos de los fármacos , Ileítis/inmunología , Ileítis/patología , Íleon/irrigación sanguínea , Íleon/efectos de los fármacos , Íleon/patología , Cadenas beta de Integrinas/metabolismo , Mucosa Intestinal/irrigación sanguínea , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Ratones , Ratones Endogámicos AKR , Microscopía Fluorescente , Microvasos/efectos de los fármacos , Microvasos/patología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores CCR/metabolismo , Linfocitos T/patología , Linfocitos T/fisiología , Tretinoina/metabolismo
4.
Inflamm Bowel Dis ; 14(10): 1348-57, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18484673

RESUMEN

BACKGROUND: Although the immunoregulatory effects of omega-3 fatty acid and adiponectin have been postulated, their role in intestinal inflammation is controversial. The aim of this study was to determine whether dietary fat intake influences activity of colonic inflammation through modulating this system. METHODS: C57BL/6 mice received dextran sulfate sodium for induction of colitis. Mice were fed a control diet, omega-3 fat-rich diet, omega-6 fat-rich diet, or saturated fat-rich diet. Some mice were administered a peroxisome proliferator activated receptor-gamma; agonist, pioglitazone. Messenger RNA expression of adiponectin and its receptors were analyzed. Adiponectin expression in colonic mucosa of ulcerative colitis patients was also analyzed. RESULTS: The receptors for adiponectin were found to be ubiquitously expressed in epithelial cells, intraepithelial lymphocytes, lamina proprial mononuclear cells, and subepithelial myofibroblasts from colonic tissue, but adiponectin was only expressed in myofibroblasts. Induction of colitis significantly decreased the expression of adiponectin in colonic mucosa. The omega-3 fat diet group, but not the other fat diet groups, showed exacerbated colitis with a further decrease of adiponectin expression. Pioglitazone treatment ameliorated the level of decrease in adiponectin expression and improved colonic inflammation induced by the omega-3 fat-rich diet. In patients with ulcerative colitis, the expression level of adiponectin in colonic mucosa was also decreased compared with that in control mucosa. CONCLUSIONS: Adiponectin was found to be expressed in myofibroblasts. Adiponectin expression was significantly suppressed by induction of colitis, and aggravation of colitis after exposure to omega-3 fat may be due to a further decrease in the expression level of adiponectin.


Asunto(s)
Adiponectina/metabolismo , Colitis/inducido químicamente , Colitis/tratamiento farmacológico , Grasas Insaturadas en la Dieta/administración & dosificación , Ácidos Grasos Omega-3/administración & dosificación , Mioblastos/metabolismo , Adiponectina/genética , Animales , Antiinflamatorios/administración & dosificación , Células Cultivadas , Colitis/metabolismo , Colitis/patología , Sulfato de Dextran/toxicidad , Grasas de la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Ácidos Grasos Omega-6/administración & dosificación , Expresión Génica , Humanos , Mucosa Intestinal/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Pioglitazona , ARN Mensajero/metabolismo , Distribución Aleatoria , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tiazolidinedionas
5.
Int J Cancer ; 117(3): 499-505, 2005 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-15906361

RESUMEN

Most cases of pancreatic cancer are inoperable when diagnosed. Since immunotherapy and antiangiogenic therapy have been reported to be promising for pancreatic cancer, we examined whether the combination of immunotherapy with dendritic cells (DCs) and the antiangiogenic drug TNP-470 induces tumor regression. Syngeneic mouse pancreatic adenocarcinoma cells were orthotopically inoculated into C57/BL6 mice. DCs with or without tumor lysate (TL) were administered i.p. at 4 and 5 weeks. TNP-470 was injected s.c. into tumor-bearing mice every other day from 4 weeks to 6 weeks. We compared anticancer effects in 6 groups: NT (no treatment), DC/TL- (DCs without TL), DC/TL+ (DCs pulsed with TL), TNP (TNP-470 alone), DC/TL-TNP (DC/TL- plus TNP-470) and DC/TL+TNP (DC/TL+ plus TNP-470). We measured tumor volume, mean vascular density (MVD) and vessel diameter by FITC-dextran using an intravital microscope; degrees of proliferation and apoptosis of cancer cells by PCNA and TUNEL; infiltrating lymphocytes and expression levels of VEGF and MMP-9 by immunohistochemistry and immunoblotting. Tumor volume and MVD were significantly suppressed in the treatment groups with prolonged survival rate, especially in the DC/TL+TNP group. There were no significant differences in apoptosis among the 6 groups except DC/TL+. The number of infiltrating CD4+ cells in the DC/TL+ group was higher than that in the NT group. VEGF expression was significantly suppressed in the treatment groups containing TNP-470, and MMP-9 was also suppressed in the groups containing DC/TL+. Our data suggested that TL-pulsed DCs combined with TNP-470 induced regression of mouse pancreatic cancer, possibly through induction of immune responses and suppression of angiogenesis.


Asunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Antibióticos Antineoplásicos/uso terapéutico , Células Dendríticas/inmunología , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/inmunología , Sesquiterpenos/uso terapéutico , Adenocarcinoma/irrigación sanguínea , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/inmunología , Adenocarcinoma/patología , Animales , División Celular , Supervivencia Celular , Terapia Combinada , Ciclohexanos , Modelos Animales de Enfermedad , Inmunoterapia , Activación de Linfocitos , Transfusión de Linfocitos , Ratones , O-(Cloroacetilcarbamoil) Fumagilol , Neoplasias Pancreáticas/irrigación sanguínea , Neoplasias Pancreáticas/patología , Bazo/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA